RTTNews BiotechDoubao · 实盘不做把握 7/10不做原因:已被定价
北京时间·🕒 发布 18:45:09·⟳ 抓取 19:00:23 +15m14s·⚡ 决策 09-14 19:03:15 +2m52s·43.4 天前
Telix制药Pixclara（18F-FET）获FDA批准成为美国首个用于胶质瘤的FET-PET显像剂
这是一次日程内、高预期的FDA批准（4月NDA获受理、9月PDUFA日期市场已知，此前还经历过CRL后再申报），不是意外利好；产品为诊断显像剂、收入兑现慢且量级有限，而股价13周内大幅上行、处于52周高点附近，盘前已即时上涨6-9%，OTC ADR流动性薄弱，剩余edge不足以覆盖sell-the-news与FOMC前波动风险。
📄 原文RTTNews Biotech↗ 原文
Telix's Pixclara Wins FDA Approval For Glioma Imaging In Adults And Children
Business Business Latest Headlines Top Stories Breaking News Earnings Biotech Investors Stock Alerts IPOs M&A Canadian…
不做 Telix Pharmaceuticals（ADR）（TLX.US）
预期内的9月PDUFA获批而非新增surprise；盘前已高开6-9%实时price-in，诊断显像剂对38亿美元市值短期增量有限，OTC ADR流动性差且距FOMC仅2天，追高风险收益比不足，不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Pixclara获批为美国首个FET-PET胶质瘤显像剂，确属正面监管里程碑；但该批准在已知PDUFA日程内、盘前已大涨重定价，诊断用药对38亿美元市值的短期增量有限且ADR成交清淡，预期差与可执行性均不足，回避追高。
消息传播链
- 公司宣布FDA批准Pixclara，为美国首个FET-PET胶质瘤显像剂；官网标注Melbourne/Indianapolis 9月14日通稿
- RTTNews同步报道并给出盘前价12.30美元、+8.95%，显示消息在盘前快速被定价
- 2026-09-14 07:01 ET市场反应Futu行情非一手TLX.US盘前价约12.00美元、+6.29%（盘前区间11.75-12.38，成交约1.26万股），隔夜时段一度+7.9%；价格已反映批准利好市场反应:盘前高开6-9%，但量能薄弱
关键理由
- 首个FET-PET显像剂具先发意义且NCCN指南已有使用基础，叠加脑转移适应症扩展期权，构成中长期正面叙事
- 批准状态迁移明确（PDUFA→获批），消除了CRL尾部风险
主要风险
- 9月PDUFA为公开日程、市场早有预期，盘前+6~9%已在实时定价，监管明牌落地后常见高开低走
- 诊断显像剂需建显像中心网络与医保覆盖，24,000例患者池下单患者收入贡献对38亿美元市值弹性小，且2天后FOMC放大概率压制风险偏好
反向证据
- 做多前查反向 · 来源 web · 日期 2026-09-13 · 影响 weakens
检索到《Pixclara Was Approved. The Balance Sheet Was Not.》等看空/谨慎解读，叠加前期股价大涨与盘前高开，削弱追多赔率
检索:Telix Pixclara approval expected PDUFA sell the news balance sheet cash 2026 原文 ↗
先例如何影响了这次决策
对本次决策的影响:先例证据不足本身不构成AVOID理由；最终回避主要基于预期内催化、盘前已重定价、量级有限与流动性差，符合经验检查表的反方条件
方向:未构建经首发锚校验的同类先例面板
涨幅量级:缺乏同市场（美股诊断显像剂PDUFA获批）高相似、锚干净先例，不用任何数字校准涨幅
形态:生物医药经验提示：日程内PDUFA获批、股价前期已抢跑时，盘前高开后常见sell-the-news/高开低走，但本次未用真实日线先例量化
工具执行结果 · 成功 6 · 降级 0 · 失败 1 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 37 ms
{"result": "search_processed_events:agent query=`telix pharmaceuticals pixclara fda approval glioma fet-pet floretyrosine f 18 | tlx fda approves pixclara 18f-fet brain cancer imaging adults children`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 0.0/72 小时、0 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候选，不能据此证明消息首发或不 - fetch_decision_experience 成功 stock_tools HTTP · 57 ms
{ - direct_instrument_candidates 成功 stock_tools HTTP · 73 ms
{ - stock_quote 成功 stock_tools HTTP · 662 ms
{ - web_search 成功 doubao_search · 2,130 ms
豆包搜索结果（原始查询:Telix Pixclara FDA approval glioma 18F-FET press release September 2026；API SearchType:web） - web_search 成功 doubao_search · 1,451 ms
豆包搜索结果（原始查询:Telix Pixclara PDUFA date September 2026 analyst expected approval peak sales glioma FET-PET；API SearchType:web） - kb_search 失败 stock_tools HTTP · 18,050 ms
kb_search 服务暂不可用；这不是一条知识库命中。
原文全文
展开原文 · 9,488 字
Telix's Pixclara Wins FDA Approval For Glioma Imaging In Adults And Children
Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Biotech Daily Dose
Telix's Pixclara Wins FDA Approval For Glioma Imaging In Adults And Children
By
RTTNews Staff Writer
✉
Published:
9/14/2026 6:45 AM ET
Follow Us
Join Us
Add
as your preferred news source on Google
Add Now
Telix Pharmaceuticals Limited (
TLX
) announced that the U.S. Food and Drug Administration (FDA) has approved Pixclara (floretyrosine F 18 or 18F-FET), an amino acid positron emission tomography (PET) imaging drug for glioma, or brain cancer.
Pixclara is indicated for use with PET to differentiate recurrent or progressive glioma from treatment-related change, in conjunction with other diagnostic evaluations, in adults and pediatric patients 1 month of age and older.
The approval makes Pixclara the first FDA-approved FET-PET imaging drug for glioma in the U.S. FET-PET imaging is recommended in international clinical practice guidelines, including the NCCN Guidelines, but no FDA-approved FET-PET product had previously been available in the country.
Gliomas account for approximately 30% of all brain and central nervous system (CNS) tumors and 80% of malignant brain tumors.
About 24,000 new glioma cases are diagnosed annually in the U.S., highlighting the significant unmet need for improved brain cancer imaging.
Kevin Richardson, Chief Executive Officer of Telix Precision Medicine, said the approval will enable broader U.S. access to FET-PET imaging and provide physicians with greater certainty in diagnosis and treatment planning for patients with glioma.
Pixclara is an intravenous PET imaging drug containing fluorine-18. Following administration, it targets L-type amino acid transporters 1 and 2 (LAT1 and LAT2), with emissions from the radioisotope detected by a PET scanner.
Telix is also evaluating Pixclara in a Phase 3 registrational study for a potential indication expansion into the diagnosis of brain metastases.
About Pixclara
Pixclara is a radioactive diagnostic drug indicated for PET imaging to differentiate recurrent or progressive glioma from treatment-related change, alongside other diagnostic evaluations.
The safety of Pixclara was evaluated in 382 patients with gliomas, including 371 adults and 11 pediatric patients. Headache was the only adverse reaction reported in at least 0.5% of patients, occurring in 0.5% of those treated.
TLX has traded between $6.28 and $12.48 over the past year. The stock closed Friday's trading (September 11, 2026) at $11.29, down 5.13%. In pre-market trading the stock is at $12.30, up 8.95%.
For comments and feedback contact: editorial@rttnews.com
Business News
Slide Shows
Biotech Stocks Facing FDA Decision In September 2026
Biotech Stocks Facing FDA Decision In August 2026
Biotech Stocks Facing FDA Decision In July 2026
Latest Updates on Middle East War
U.S. Dollar Ticks Higher Amid Inflation Data Release, Expectations Of Reopening Of Strait Of Hormuz
September 11, 2026 17:00 ET
Crude Oil Slumps Amid Rising Expectations Of An End To Hormuz Crisis, Profit-taking
September 11, 2026 14:41 ET
U.S. Dollar Advances Amid Oil-Linked Inflation Concerns, PPI Data Release
September 10, 2026 17:00 ET
U.S. Stocks Show Significant Rebound As Crude Oil Pulls Back Sharply
September 11, 2026 16:13 ET
Canadian Stocks Tumble Amid Increasing Concerns Of Oil-linked Inflation, Canada-U.S. Tariff War
September 10, 2026 16:32 ET
View More
Global Economics Weekly Update - Sep 07 – Sep 11, 2026
September 11, 2026 16:26 ET
Consumer prices data was the main news on the economic front in the U.S. this week. In Europe, the latest interest rate decision from the European Central Bank was the focus along with the revised second quarter economic growth data for the euro area. In Asia, the monthly foreign trade data from China drew attention.
View More Videos
RELATED NEWS
Telix's Pixclara Wins FDA Approval For Glioma Imaging In Adults And Children
Telix Completes Patient Enrollment In BiPASS Trial, Aligns With FDA On NDA Filing; Stock Up
6 After-Hours Healthcare Gainers: Universe Pharma, BioAffinity, Modular Medical, Telix Pharma & More
Telix Appoints Gill As Board Chairman
Telix Pharma H1 Revenue Jumps 22%; Reaffirms FY2026 Revenue Guidance; Stock Up
Latest Updates on COVID-19
COVID-19 Sees Late-Summer Rise Across 49 US States
September 03, 2026 12:52 ET
COVID-19 Infections Rising In All 50 US States, CDC Data Shows
August 20, 2026 14:09 ET
COVID-19 Pandemic Linked To Higher Loneliness And Isolation In England, Study Finds
August 19, 2026 14:02 ET
View More
Editor's Pick
Most Read
Most Emailed
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Apple Unveils IPhone Duo, Its First Foldable IPhone
September 09, 2026 14:42 ET
Google To Invest 13 Bln Euros In Finland To Develop AI Infra, Clean Energy
September 09, 2026 09:11 ET
Inditex H1 Profit Rises, Margin Flat, Backs FY26 Stable Margin View; Stock Drops
September 09, 2026 05:48 ET
Inditex H1 Profit Rises, Margin Flat, Backs FY26 Stable Margin View; Stock Drops
September 09, 2026 05:48 ET
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Orion180 Plans Up To $340 Mln IPO
September 09, 2026 08:04 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
HP Partners With Red Hat For AI Workloads; Shares Up
September 09, 2026 15:46 ET
Apple Unveils New AirPods And Apple Watch Lineup With Enhanced Audio, Health And AI Features
September 09, 2026 16:47 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Blackstone To Buy Flow Control Holdings From Audax For Undisclosed Terms
September 10, 2026 11:20 ET
Atlantic HPC Group To Go Public Via Aperture AC Merger
September 11, 2026 08:16 ET
SEALSQ H1 Loss Widens From Higher Expenses; Reaffirms FY26 Outlook
September 11, 2026 13:24 ET
Ageas Completes Sale Of 30.95% Maybank Ageas Stake To Maybank For EUR 1.1 Bln
September 11, 2026 01:43 ET
Sasol Agrees To Sell Nitrates Business To Enaex Africa; Retains 23% Stake
September 09, 2026 03:49 ET
E79 Gold Mines Limited Full Year Sales Increase
September 09, 2026 01:00 ET
Everpure To Join S&P 500
September 09, 2026 01:09 ET
Scientex Berhad Q4 Income Climbs
September 09, 2026 01:12 ET
Chime To Acquire Stride Bank
September 09, 2026 01:26 ET
Antin Infrastructure Partners SAS Profit Drops In H1
September 09, 2026 01:29 ET
Vallourec, Aramco Ink Agreement For Supply Of Oil Country Tubular Goods
September 09, 2026 01:45 ET
Freemelt Secures SEK 84 Mln Order From Fusion For Energy To Manufacture Fusion Units
September 09, 2026 01:46 ET
TINC Comm VA Bottom Line Advances In H1
September 09, 2026 02:01 ET
Barnes & Noble Education Q1 Net Loss Narrows As Revenue Improves
September 09, 2026 02:04 ET
AUTO1 Group CFO Christian Wallentin Steps Down, CEO Christian Bertermann To Take Over As Interim
September 09, 2026 02:09 ET
Freemelt Targets Positive EBITDA In 2028; Reaffirms SEK 1 Bln Order Intake Goal By 2030
September 09, 2026 02:10 ET
The Gym Group Plc Reveals Climb In H1 Bottom Line
September 09, 2026 02:14 ET
Editors Pick
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Apple Unveils IPhone Duo, Its First Foldable IPhone
September 09, 2026 14:42 ET
Loading...
Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Biotech Daily Dose
Telix's Pixclara Wins FDA Approval For Glioma Imaging In Adults And Children
By
RTTNews Staff Writer
✉
Published:
9/14/2026 6:45 AM ET
Follow Us
Join Us
Add
as your preferred news source on Google
Add Now
Telix Pharmaceuticals Limited (
TLX
) announced that the U.S. Food and Drug Administration (FDA) has approved Pixclara (floretyrosine F 18 or 18F-FET), an amino acid positron emission tomography (PET) imaging drug for glioma, or brain cancer.
Pixclara is indicated for use with PET to differentiate recurrent or progressive glioma from treatment-related change, in conjunction with other diagnostic evaluations, in adults and pediatric patients 1 month of age and older.
The approval makes Pixclara the first FDA-approved FET-PET imaging drug for glioma in the U.S. FET-PET imaging is recommended in international clinical practice guidelines, including the NCCN Guidelines, but no FDA-approved FET-PET product had previously been available in the country.
Gliomas account for approximately 30% of all brain and central nervous system (CNS) tumors and 80% of malignant brain tumors.
About 24,000 new glioma cases are diagnosed annually in the U.S., highlighting the significant unmet need for improved brain cancer imaging.
Kevin Richardson, Chief Executive Officer of Telix Precision Medicine, said the approval will enable broader U.S. access to FET-PET imaging and provide physicians with greater certainty in diagnosis and treatment planning for patients with glioma.
Pixclara is an intravenous PET imaging drug containing fluorine-18. Following administration, it targets L-type amino acid transporters 1 and 2 (LAT1 and LAT2), with emissions from the radioisotope detected by a PET scanner.
Telix is also evaluating Pixclara in a Phase 3 registrational study for a potential indication expansion into the diagnosis of brain metastases.
About Pixclara
Pixclara is a radioactive diagnostic drug indicated for PET imaging to differentiate recurrent or progressive glioma from treatment-related change, alongside other diagnostic evaluations.
The safety of Pixclara was evaluated in 382 patients with gliomas, including 371 adults and 11 pediatric patients. Headache was the only adverse reaction reported in at least 0.5% of patients, occurring in 0.5% of those treated.
TLX has traded between $6.28 and $12.48 over the past year. The stock closed Friday's trading (September 11, 2026) at $11.29, down 5.13%. In pre-market trading the stock is at $12.30, up 8.95%.
For comments and feedback contact: editorial@rttnews.com
Business News
Slide Shows
Biotech Stocks Facing FDA Decision In September 2026
Biotech Stocks Facing FDA Decision In August 2026
Biotech Stocks Facing FDA Decision In July 2026
Latest Updates on Middle East War
U.S. Dollar Ticks Higher Amid Inflation Data Release, Expectations Of Reopening Of Strait Of Hormuz
September 11, 2026 17:00 ET
Crude Oil Slumps Amid Rising Expectations Of An End To Hormuz Crisis, Profit-taking
September 11, 2026 14:41 ET
U.S. Dollar Advances Amid Oil-Linked Inflation Concerns, PPI Data Release
September 10, 2026 17:00 ET
U.S. Stocks Show Significant Rebound As Crude Oil Pulls Back Sharply
September 11, 2026 16:13 ET
Canadian Stocks Tumble Amid Increasing Concerns Of Oil-linked Inflation, Canada-U.S. Tariff War
September 10, 2026 16:32 ET
View More
Global Economics Weekly Update - Sep 07 – Sep 11, 2026
September 11, 2026 16:26 ET
Consumer prices data was the main news on the economic front in the U.S. this week. In Europe, the latest interest rate decision from the European Central Bank was the focus along with the revised second quarter economic growth data for the euro area. In Asia, the monthly foreign trade data from China drew attention.
View More Videos
RELATED NEWS
Telix's Pixclara Wins FDA Approval For Glioma Imaging In Adults And Children
Telix Completes Patient Enrollment In BiPASS Trial, Aligns With FDA On NDA Filing; Stock Up
6 After-Hours Healthcare Gainers: Universe Pharma, BioAffinity, Modular Medical, Telix Pharma & More
Telix Appoints Gill As Board Chairman
Telix Pharma H1 Revenue Jumps 22%; Reaffirms FY2026 Revenue Guidance; Stock Up
Latest Updates on COVID-19
COVID-19 Sees Late-Summer Rise Across 49 US States
September 03, 2026 12:52 ET
COVID-19 Infections Rising In All 50 US States, CDC Data Shows
August 20, 2026 14:09 ET
COVID-19 Pandemic Linked To Higher Loneliness And Isolation In England, Study Finds
August 19, 2026 14:02 ET
View More
Editor's Pick
Most Read
Most Emailed
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Apple Unveils IPhone Duo, Its First Foldable IPhone
September 09, 2026 14:42 ET
Google To Invest 13 Bln Euros In Finland To Develop AI Infra, Clean Energy
September 09, 2026 09:11 ET
Inditex H1 Profit Rises, Margin Flat, Backs FY26 Stable Margin View; Stock Drops
September 09, 2026 05:48 ET
Inditex H1 Profit Rises, Margin Flat, Backs FY26 Stable Margin View; Stock Drops
September 09, 2026 05:48 ET
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Orion180 Plans Up To $340 Mln IPO
September 09, 2026 08:04 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
HP Partners With Red Hat For AI Workloads; Shares Up
September 09, 2026 15:46 ET
Apple Unveils New AirPods And Apple Watch Lineup With Enhanced Audio, Health And AI Features
September 09, 2026 16:47 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Blackstone To Buy Flow Control Holdings From Audax For Undisclosed Terms
September 10, 2026 11:20 ET
Atlantic HPC Group To Go Public Via Aperture AC Merger
September 11, 2026 08:16 ET
SEALSQ H1 Loss Widens From Higher Expenses; Reaffirms FY26 Outlook
September 11, 2026 13:24 ET
Ageas Completes Sale Of 30.95% Maybank Ageas Stake To Maybank For EUR 1.1 Bln
September 11, 2026 01:43 ET
Sasol Agrees To Sell Nitrates Business To Enaex Africa; Retains 23% Stake
September 09, 2026 03:49 ET
E79 Gold Mines Limited Full Year Sales Increase
September 09, 2026 01:00 ET
Everpure To Join S&P 500
September 09, 2026 01:09 ET
Scientex Berhad Q4 Income Climbs
September 09, 2026 01:12 ET
Chime To Acquire Stride Bank
September 09, 2026 01:26 ET
Antin Infrastructure Partners SAS Profit Drops In H1
September 09, 2026 01:29 ET
Vallourec, Aramco Ink Agreement For Supply Of Oil Country Tubular Goods
September 09, 2026 01:45 ET
Freemelt Secures SEK 84 Mln Order From Fusion For Energy To Manufacture Fusion Units
September 09, 2026 01:46 ET
TINC Comm VA Bottom Line Advances In H1
September 09, 2026 02:01 ET
Barnes & Noble Education Q1 Net Loss Narrows As Revenue Improves
September 09, 2026 02:04 ET
AUTO1 Group CFO Christian Wallentin Steps Down, CEO Christian Bertermann To Take Over As Interim
September 09, 2026 02:09 ET
Freemelt Targets Positive EBITDA In 2028; Reaffirms SEK 1 Bln Order Intake Goal By 2030
September 09, 2026 02:10 ET
The Gym Group Plc Reveals Climb In H1 Bottom Line
September 09, 2026 02:14 ET
Editors Pick
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Apple Unveils IPhone Duo, Its First Foldable IPhone
September 09, 2026 14:42 ET
Loading...
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。